Electromed

ELMD

Market cap $304M

Electromed (ELMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

GOLD, ELMD and TPR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 2nd, 2026.

GOLD, ELMD, TPR, PLGO and CRGY have been added to the Zacks Rank #1 (Strong Buy) List on June 2nd, 2026.

Electromed (ELMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

GenAI is reshaping medical instruments as Electromed, Globus Medical and Intuitive Surgical navigate M&A and market pressures.

Electromed, Inc. (ELMD) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ELMD's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.

Electromed (ELMD) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

HCSG, ELMD, UMBF, SHEL and MTSI passed an efficiency screen based on turnover ratios, asset use and operating margin strength.

Electromed (ELMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.